alendronate has been researched along with Acute Disease in 10 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alendronate is an aminobisphosphonate that is able to increase bone mass mainly by inhibiting bone resorption." | 6.69 | Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. ( Colao, A; Di Somma, C; Faggiano, A; Klain, M; Lombardi, G; Merola, B; Pivonello, R; Salvatore, M; Tripodi, FS, 1998) |
| "Granulomatous interstitial nephritis is a rare but characteristic hallmark of certain diseases such as sarcoidosis and tuberculosis." | 5.33 | Acute granulomatous interstitial nephritis secondary to bisphosphonate alendronate sodium. ( Fervenza, FC; Habermann, T; Lager, D; Leung, N; Peña de la Vega, L, 2005) |
| "Alendronate is an aminobisphosphonate that is able to increase bone mass mainly by inhibiting bone resorption." | 2.69 | Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. ( Colao, A; Di Somma, C; Faggiano, A; Klain, M; Lombardi, G; Merola, B; Pivonello, R; Salvatore, M; Tripodi, FS, 1998) |
| "Granulomatous interstitial nephritis is a rare but characteristic hallmark of certain diseases such as sarcoidosis and tuberculosis." | 1.33 | Acute granulomatous interstitial nephritis secondary to bisphosphonate alendronate sodium. ( Fervenza, FC; Habermann, T; Lager, D; Leung, N; Peña de la Vega, L, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vaishya, R | 1 |
| Vijay, V | 1 |
| Vaish, A | 1 |
| Berry, SD | 1 |
| Misra, D | 1 |
| Hannan, MT | 1 |
| Kiel, DP | 1 |
| Strowd, RE | 1 |
| Agborbesong, P | 1 |
| Eapen, M | 1 |
| Ervin, S | 1 |
| Gerster, JH | 1 |
| Pitocco, D | 2 |
| Ruotolo, V | 2 |
| Caputo, S | 2 |
| Mancini, L | 2 |
| Collina, CM | 1 |
| Manto, A | 2 |
| Caradonna, P | 2 |
| Ghirlanda, G | 2 |
| Peña de la Vega, L | 1 |
| Fervenza, FC | 1 |
| Lager, D | 1 |
| Habermann, T | 1 |
| Leung, N | 1 |
| Gilchrist, NL | 1 |
| Frampton, CM | 1 |
| Acland, RH | 1 |
| Nicholls, MG | 1 |
| March, RL | 1 |
| Maguire, P | 1 |
| Heard, A | 1 |
| Reilly, P | 1 |
| Marshall, K | 1 |
| Collina, MC | 1 |
| Musella, T | 1 |
| Galli, M | 1 |
| Di Somma, C | 1 |
| Colao, A | 1 |
| Pivonello, R | 1 |
| Klain, M | 1 |
| Faggiano, A | 1 |
| Tripodi, FS | 1 |
| Merola, B | 1 |
| Salvatore, M | 1 |
| Lombardi, G | 1 |
| Cadario, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Treatment With DENOsumab of an Acute CHARCOT Foot in Patients With Diabetes. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial.[NCT04547348] | Phase 3 | 38 participants (Anticipated) | Interventional | 2020-11-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for alendronate and Acute Disease
| Article | Year |
|---|---|
Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy.
Topics: Acute Disease; Alendronate; Arthropathy, Neurogenic; Bone Density Conservation Agents; Bone Resorpti | 2008 |
4 trials available for alendronate and Acute Disease
| Article | Year |
|---|---|
Low acceptance of treatment in the elderly for the secondary prevention of osteoporotic fracture in the acute rehabilitation setting.
Topics: Acute Disease; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Calcium; Chol | 2010 |
Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial.
Topics: Acute Disease; Alendronate; Arthropathy, Neurogenic; Bone Resorption; Diabetic Neuropathies; Disabil | 2005 |
Alendronate prevents bone loss in patients with acute spinal cord injury: a randomized, double-blind, placebo-controlled study.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Alendronate; Body Height; Body Mass Index; B | 2007 |
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease.
Topics: Acute Disease; Adult; Alendronate; Antifungal Agents; Biomarkers; Bone Density; Collagen; Collagen T | 1998 |
5 other studies available for alendronate and Acute Disease
| Article | Year |
|---|---|
Spontaneous osteonecrosis of the knee: an unusual cause of knee pain.
Topics: Acute Disease; Adult; Alendronate; Arthralgia; Diclofenac; Disease Progression; Humans; Knee Joint; | 2014 |
Intramural hematoma of the esophagus presenting as chest pain.
Topics: Acute Disease; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Chest Pain; Dietary | 2010 |
Acute polyarthritis related to once-weekly alendronate in a woman with osteoporosis.
Topics: Acute Disease; Alendronate; Arthralgia; Arthritis; Drug Administration Schedule; Female; Humans; Joi | 2004 |
Acute granulomatous interstitial nephritis secondary to bisphosphonate alendronate sodium.
Topics: Acute Disease; Acute Kidney Injury; Aged; Alendronate; Biopsy, Needle; Female; Follow-Up Studies; Hu | 2005 |
Alendronate: suspected pancreatitis.
Topics: Acute Disease; Aged; Alendronate; Female; Humans; Male; Pancreatitis | 2002 |